19 June 2013
Keywords: Merck & Co, Idera Pharma, vacine candidates selection
Article | 10 January 2012
Idera Pharmaceuticals (Nasdaq: IDRA) says that US drugs giant that Merck & Co (NYSE: MRK) has selected several novel Toll-like ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
10 January 2012
18 June 2013
© 2013 thepharmaletter.com